Found 7 matching trials
A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease
PHASE1This is a study to evaluate the safety, tolerability and blood levels of PF...
Location
Pfizer Investigational Site
A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
PHASE2The purpose of this study is to determine whether PF-03654746 is effective ...
Location
Bay Area Research Institute
A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge
PHASE2An H3 receptor antagonist should reduce the congestion associated with alle...
Location
Pfizer Investigational Site
Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
PHASE2The purpose of this study is to evaluate the safety and efficacy of an inve...
Location
Pfizer Investigational Site
Add On Treatment for Cognitive Deficits in Schizophrenia
PHASE1This study will look at the impact of dosing as well as ongoing treatment w...
Location
University of Pennsylvania
A Phase I, Healthy Volunteer Positron Emission Tomography Study
PHASE1The primary purpose of this study is to assess central receptor occupancy o...
Location
Pfizer Investigational Site
A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy
PHASE2Histaminergic agents are known to be involved with the sleep/wake cycle. Th...
Location
Pfizer Investigational Site